DEPARTMENT OF HEALTH MD HJMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES CF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
WORKING GROUP ON HUMAN GENE THERAPY 
MINUTES OF MEETING 1 
OCTOBER 12, 1984 
The Working Group on Human Gene Therapy of the Recombinant ENA Advisory Ccmmittee 
was convened at 9:00 a.m. on October 12, 1984, at the National Institutes of 
Health, Building 31C, Conference Room 9, 9000 Rockville Pike, Bethesda, Maryland 
20205. The meeting was open to the public. Dr. LeRoy Walters was chair. The 
fo Hewing people were present for all or part of the meeting: 
Working Group Members: 
W. French Anderson 
Judith Areen 
Richard Axel 
Alexander Capron 
James Childress 
Samuel Gorovitz 
Susan Gottesman 
Clifford Grobetein 
Maurice Mahoney 
Robert Mitchell 
Amo Mot ul sky 
Robert Murray 
Harold Varmus 
LeRcy Walters 
William Gartland 
(Executive Secretary) 
A working group roster is attached (Attachment I). 
Liaison Representatives : 
Charles McCarthy, National Institutes of Health 
Henry Miller, Pood and Drug Administration 
Other National Institutes of Health Staff: 
Stanley Bar ban, NIAID 
Fred Bergmann, NIGMS 
Irene Eckstrand, NIGMS 
Elizabeth Milewski, NIAID 
Others: 
Irene Brandt, Eli Lilly and Company 
Karen Ekelman, University of Maryland 
Judy Johnson, Library of Congress 
Herman Lewis, National Science Foundation 
Kim McDonald, Chronicle of Higher Education 
Robert Mullan Cook-Deegan, Office of Technology Assessment, U.S. Congress 
Greg Pearson, The Blue Sheet 
Jchn Sharp, Eli Lilly and Company 
^The working group is advisory to the RAC, and its recommendations should not 
be considered as final or accepted. 
[ 89 ] 
